Adjunctive therapy is any treatment used alongside a primary treatment to help it work better. If surgery is your main cancer treatment, the chemotherapy you receive afterward is adjunctive. If an antidepressant isn’t fully controlling your symptoms, a second medication added to boost its effect is adjunctive. The concept is simple: one treatment supports another, and together they achieve more than either would alone.
How Adjunctive Therapy Works
The core idea is that many conditions are too complex for a single treatment to handle completely. A primary treatment does the heavy lifting, and an adjunctive treatment fills in the gaps. Those gaps might be residual disease that the first treatment can’t reach, side effects that need managing, or biological pathways that require a different approach to shut down.
At the biological level, adjunctive treatments often work through complementary mechanisms. One treatment might target a disease directly while the other blocks a resistance pathway or improves the body’s ability to absorb the first drug. This is sometimes called synergy, where two treatments together produce a greater effect than you’d expect from simply adding their individual benefits. In cancer care, for example, certain plant-based compounds have been shown to enhance the effectiveness of chemotherapy drugs while simultaneously reducing their side effects.
Adjunctive vs. Neoadjuvant vs. Monotherapy
These terms sound interchangeable but describe very different strategies. Adjunctive (or adjuvant) therapy comes after the primary treatment. In cancer, this typically means treatment given after surgery to kill any remaining cancer cells that can’t be seen. Neoadjuvant therapy is the opposite: it’s given before the primary treatment, often to shrink a tumor so surgery becomes easier or more effective.
Monotherapy means using a single treatment on its own. When a doctor prescribes one antidepressant and nothing else, that’s monotherapy. The moment a second agent is added to support the first, you’ve moved into adjunctive territory.
Common Uses in Cancer Treatment
Cancer is where most people encounter the term. After a surgeon removes a tumor, there’s always a concern that microscopic cancer cells remain in the body. Adjunctive therapy targets those invisible remnants. The Mayo Clinic describes five types commonly used this way: chemotherapy, radiation therapy, immunotherapy (which helps the immune system recognize and attack cancer cells), hormone therapy (which blocks hormones that fuel certain cancers), and targeted therapy (which attacks specific chemicals inside cancer cells to kill them).
The specific combination depends on the type and stage of cancer. Breast cancer patients, for instance, might receive hormone therapy for years after surgery to suppress the hormones that helped their cancer grow. A 2024 FDA approval illustrates how the field keeps expanding: a fluorescence imaging agent called pegulicianine was approved as an adjunct during lumpectomy surgery, helping surgeons identify cancerous tissue that might otherwise be missed during the procedure.
Common Uses in Mental Health
In psychiatry, adjunctive therapy most often comes up when a first-line medication isn’t enough. Treatment-resistant depression, broadly defined as depression that doesn’t respond adequately to one or more antidepressants at proper doses and duration, is one of the most common reasons doctors add a second medication rather than simply switching drugs.
Several classes of medication are FDA-approved specifically for adjunctive use in depression. These include certain atypical antipsychotics, which, despite the name, are effective mood stabilizers when paired with an antidepressant. An esketamine nasal spray is also approved for treatment-resistant depression, used alongside an oral antidepressant. Other options that doctors sometimes add include mood stabilizers and thyroid hormone supplements, though these are used off-label based on clinical evidence rather than formal FDA approval for this purpose.
The decision to add an adjunctive medication in depression typically follows a structured evaluation. Doctors look at whether the original medication was taken consistently, whether the dose was adequate, and whether other conditions like sleep apnea or chronic pain might be worsening symptoms. These factors matter because they can mimic treatment resistance when the real problem lies elsewhere.
Non-Drug Adjunctive Treatments
Adjunctive therapy doesn’t have to be a pill. Physical therapy, acupuncture, meditation, massage, talk therapy, and biofeedback are all used alongside medications in chronic pain management, mental health treatment, and rehabilitation. In chronic pain specifically, adding non-drug approaches can sometimes allow you to take a lower dose of pain medication, reducing the risk of side effects.
Physical therapy uses exercise, heat, cold, and hands-on manipulation to condition muscles and restore strength. Cognitive behavioral therapy helps people change thought patterns that amplify pain or depression. Biofeedback teaches you to consciously influence body functions like heart rate and muscle tension using real-time electronic feedback. Electrical nerve stimulation delivers gentle currents to nerves or muscles, changing or blocking pain signals. These treatments rarely replace medication entirely for serious conditions, but they often improve outcomes when layered on top of a primary treatment.
Managing Side Effects With Adjunctive Therapy
Sometimes the adjunctive treatment isn’t aimed at the disease at all. It’s aimed at making the primary treatment more tolerable. This is especially common in chemotherapy, where anti-nausea medications are given routinely to control vomiting. Opioid-induced constipation is another example: specific medications exist solely to counteract this side effect so patients can continue their pain management regimen. Antibiotics frequently cause diarrhea, and probiotics are sometimes recommended alongside them to maintain gut health.
This category of adjunctive therapy is easy to overlook, but it plays a critical role in whether patients can stick with their primary treatment long enough for it to work.
Risks of Adding Treatments
Every medication added to your regimen increases the chance of a drug interaction. The numbers are stark: with two drugs, the probability of an adverse reaction is roughly 13%. With five medications, it jumps to 58%. At seven or more, it reaches 82%. These interactions happen when drugs interfere with each other’s absorption, metabolism, or effects at their target sites.
Interactions range from mild (a slight change in how well one drug is absorbed) to dangerous (significantly increased bleeding risk when blood thinners are combined with certain anti-clotting drugs). Age compounds the problem because the body’s ability to process medications changes over time, making older adults particularly vulnerable to these interactions.
This is why adjunctive therapy is a deliberate clinical decision, not just stacking treatments. The expected benefit of adding a second therapy needs to clearly outweigh the added complexity and risk. For patients already taking several medications, doctors typically review the entire medication list before adding anything new, sometimes using electronic interaction-checking tools to flag potential conflicts.